Tibra Equities Europe’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-91,200
Closed -$339K 243
2021
Q2
$339K Buy
+91,200
New +$339K 0.1% 90
2019
Q2
Sell
-22,778
Closed -$217K 481
2019
Q1
$217K Buy
+22,778
New +$217K 0.02% 366